Atractylenolide-I Attenuates MPTP/MPP+‑Mediated Oxidative Stress in Parkinson’s Disease Through SIRT1/PGC‑1α/Nrf2 Axis
Neurochemical Research · 2025
DOI: 10.1007/s11064-024-04258-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurochemical Research, 2025. Verfasst von Ya Gao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, China. Hauptthemen laut MEDLINE: Oxidative Stress, Sirtuin 1, Sesquiterpenes, Mice, Inbred C57BL. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Parkinson's disease (PD) is typically marked by motor dysfunction accompanied by loss of dopaminergic (DA) neurons and aggravated oxidative stress in the substantia nigra pars compacta (SNpc). Atractylenolide-I (ATR-I) is a potent antioxidant sesquiterpene with neuroprotective properties. However, whether ATR-I plays a neuroprotective role against oxidative stress in PD remains unclear. The objective of this study was to explore the mechanism of antioxidant action of ATR-I in PD models both in vivo and in vitro. Here, we show that ATR-I alleviated motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mice. Moreover, ATR-I treatment effectively reduced DA neuron loss and increased tyrosine hydroxylase expression in the SNpc of MPTP-induced mice. Additionally, ATR-I inhibited oxidative stress (as manifested by elevated superoxide dismutase and glutathione peroxidase activities, and reduced malondialdehyde content) in MPTP-induced mice and attenuated reactive oxygen species levels in 1-methyl-4-phenylpyridinum (MPP+)-treated SH-SY5Y cells. Finally, ATR-I upregulated expressions of silent information regulator 1 (SIRT1), peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α), NF-E2-related factor-2 (Nrf2), and heme oxygenase-1 in MPTP-induced mice and MPP+-treated SH-SY5Y cells, but had little effect on these factors in the presence of the SIRT1 inhibitor EX527. Taken together, these findings indicated that the important antioxidant role of ATR-I in MPTP/MPP+-mediated oxidative stress and the pathogenesis of PD through the SIRT1/PGC-1α/Nrf2 axis, highlighting its potential as a therapeutic option for PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, China.
- Department of Internal Medicine, Fuping County Hospital, Baoding, Hebei, 073200, China.
- Department of Neurological Rehabilitation, Children's Hospital of Hebei Province, Shijiazhuang, Hebei, 050000, China.
- Department of Geriatrics, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, China. yanggf@hebmu.edu.cn.
Zitieren
APA
Gao, Y., Li, S., Zhang, S., Zhang, Y., Zhang, J., Zhao, Y., Chang, C., Gao, X., Chen, L., & Yang, G. (2025). Atractylenolide-I Attenuates MPTP/MPP+‑Mediated Oxidative Stress in Parkinson’s Disease Through SIRT1/PGC‑1α/Nrf2 Axis. Neurochemical Research. https://doi.org/10.1007/s11064-024-04258-x
Vancouver
Gao Y, Li S, Zhang S, Zhang Y, Zhang J, Zhao Y, et al. Atractylenolide-I Attenuates MPTP/MPP+‑Mediated Oxidative Stress in Parkinson’s Disease Through SIRT1/PGC‑1α/Nrf2 Axis. Neurochemical Research. 2025. doi:10.1007/s11064-024-04258-x
BibTeX
@article{Gao2025,
author = {Gao, Ya and Li, Shuyue and Zhang, Shuming and Zhang, Yidan and Zhang, Jian and Zhao, Yuan and Chang, Cui and Gao, Xuan and Chen, Ling and Yang, Guofeng},
title = {Atractylenolide-I Attenuates MPTP/MPP+‑Mediated Oxidative Stress in Parkinson’s Disease Through SIRT1/PGC‑1α/Nrf2 Axis},
journal = {Neurochemical Research},
year = {2025},
doi = {10.1007/s11064-024-04258-x}
}
EUVIMED